03/11/2025
Skin revolution: World-first TDX-20 launch unveiled at Daydreams Skin & Body Therapy
Daydreams Skin/Body Therapy owner Sara Esler is part of a landmark moment in regenerative skincare following the unveiling of the ‘TDX-20’ device from Sisneo Bioscience to the UK spa and aesthetics industry during the inaugural Regenerative Summit. Daydreams is one of the first chosen to be part of this break-through for skin treatments and retail product using Genosomes.
Developed over ten years, the TDX-20 uses Sisneo’s ‘genosome’ technology to create ultra-concentrated serums directly in front of the client. Unlike traditional encapsulated products, which typically contain 3-4% active concentration, the TDX-20 enables up to 84% concentration, offering a new level of potency and personalisation. This approach allows spas and clinics to deliver tailored, high-performance treatments with no downtime.